Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer

scientific article published on 13 September 2018

Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/1759-7714.12862
P932PMC publication ID6209777
P698PubMed publication ID30209884

P50authorGyeong-Won LeeQ91005923
P2093author name stringSung Woo Park
Myoung Hee Kang
Hoon-Gu Kim
Se-Il Go
Hankyu Jeon
P2860cites workCancer immunoediting: from immunosurveillance to tumor escapeQ28212251
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 sQ33411909
VP-16 and cisplatin as first-line therapy for small-cell lung cancerQ33445186
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective studyQ33532808
Definition and classification of cancer cachexia: an international consensusQ34162846
Clinical pictures of malnutrition in ill elderly subjectsQ34343791
Cancer: impact of nutrition intervention outcome--nutrition issues for patientsQ34349876
Cancer cachexia, mechanism and treatmentQ34669440
New aspects of natural-killer-cell surveillance and therapy of cancerQ34988265
Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung CancerQ35754078
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.Q36200582
Assessing the performance of prediction models: a framework for traditional and novel measuresQ36617895
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?Q36694116
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneQ36804101
Significance of Onodera's prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institutionQ36834512
STAT3 in the systemic inflammation of cancer cachexia.Q36901910
Small cell lung cancer: have we made any progress over the last 25 years?Q36959597
The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.Q37080980
Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung CancerQ37205335
Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancerQ37205585
Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patientsQ37702774
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysisQ38216183
Cancer cachexia: understanding the molecular basis.Q38257741
Cachexia and sarcopenia: mechanisms and potential targets for interventionQ38480042
Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancerQ38627484
TNF-α and cancer cachexia: Molecular insights and clinical implicationsQ39029926
The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patientsQ39070636
Impaired immune function: an early marker for cancer cachexiaQ39779914
Dangers of using "optimal" cutpoints in the evaluation of prognostic factorsQ40752297
Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinomaQ41285899
Nutritional screening and early treatment of malnutrition in cancer patientsQ42117487
Prognostic nutritional index predicts outcomes of gastrectomy in the elderlyQ43489059
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsQ43517625
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatmentQ46058203
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.Q47196294
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?Q47282777
Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancerQ48061164
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.Q50789972
[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]Q70507813
The prognostic nutritional index can be a prognostic indicator in colorectal carcinomaQ82794556
Nutritional predictors of postoperative outcome in pancreatic cancerQ85226329
Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumorQ86891421
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancerQ87853206
Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell CarcinomaQ87937106
P433issue11
P407language of work or nameEnglishQ1860
P304page(s)1483-1491
P577publication date2018-09-13
P1433published inThoracic CancerQ26842004
P1476titleLow pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer
P478volume9

Reverse relations

cites work (P2860)
Q90669424Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy
Q92251631The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival

Search more.